- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0007205
_PRIVATE_LIMITED.webp)
About Acme Therapeutics (I) Private Limited
Data last updated:
Acme Therapeutics (I) Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232HR2001PTC093261. Its GSTIN is 10AADCA3220A1ZY (Bihar). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹16.23 Lakh. It was formerly known as Acme Therapeutics Private Limited and Acme Pharmaceuticals Private Limited. It is led by directors including Banshidhar Kanhaiyalal and Gopal Krishna.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.81 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹74.87 Lakh (net margin 5.1%) and EBITDA of ₹1.4 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
The company has about 302 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.25 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 14 cases involving the company, including 14 filed by the company; 4 cases are pending.
Acme Therapeutics (I) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0007205). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atipl.in.
Company details
Name history
Acme Therapeutics (I) has undergone 2 name changes throughout its history. The company was previously known as Acme Therapeutics Private Limited, and Acme Pharmaceuticals Private Limited. The current legal name is Acme Therapeutics (I) Private Limited.
| Company Name | Status |
|---|---|
| Acme Therapeutics (I) Private Limited | Current |
| Acme Therapeutics Private Limited | Previous |
| Acme Pharmaceuticals Private Limited | Previous |
CIN history
Acme Therapeutics (I) has one previous CIN (Corporate Identification Number): U24232MP2001PTC014592. The current CIN is U24232HR2001PTC093261, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232HR2001PTC093261 | Current |
| U24232MP2001PTC014592 | Previous |
Recognitions & Rankings of Acme Therapeutics (I)
Contact details
Acme Therapeutics (I) Private Limited's registered office is in Panchkula, Haryana. Its website is atipl.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Acme Therapeutics (I) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Acme Therapeutics (I) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Acme Therapeutics (I) Private Limited, buy the company report.
Financials of Acme Therapeutics (I) Private Limited
FY 2025 filings availableAcme Therapeutics (I) Private Limited reported revenue of ₹14.81 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Acme Therapeutics (I) Private Limited, buy the company report.
Board of directors of Acme Therapeutics (I) Private Limited
Acme Therapeutics (I) has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banshidhar Kanhaiyalal Also directs: Evets Drugs Private Limited, Sriram Healthcare Private Limited, Prosperity Drugs Private Limited and 2 more | Director | 14 Mar 2001 | 25 Years 8 Months | Current |
| Gopal Krishna | Director | 01 May 2002 | 24 Years 6 Months | Current |
| Sanjay Kumar | Director | 21 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Acme Therapeutics (I) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Intag Remedies Private Limited | ₹14.94 Cr (FY 2025) | 7.0% | Guwahati, Assam, India | |||
| Acme Therapeutics (I) Private Limitedthis company | ₹14.81 Cr (FY 2025) | ₹74.87 Lakh | 5.1% | -8.0% | Panchkula, Haryana, India | |
| Aashirwad Medicos Private Limited | ₹14.8 Cr (FY 2022) | 41.0% | Delhi, India | |||
| Neoastra Drugs Private Limited | ₹14.71 Cr (FY 2025) | 39.0% | Sarai Rohilla, Delhi, India |
To see the full peer comparison of Acme Therapeutics (I) Private Limited, buy the company report.
Auditor
Acme Therapeutics (I) Private Limited is audited by N.K.DAFRIA & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N.K.DAFRIA & CO. | FY 2022 | 005550C |
Shareholding
The shareholding of Acme Therapeutics (I) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Acme Therapeutics (I) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jan 2025 | 101049295 | Hdfc Bank Limited | ₹2.75 Cr | Open | |
| 13 Feb 2024 | 100875794 | Others | ₹1.5 Cr | Open | |
| 20 Mar 2020 | 100341247 | Others | ₹83.25 Lakh | Satisfied | |
| 10 Dec 2015 | 10615973 | Kotak Mahindra Bank Limited | ₹42 Lakh | Satisfied | |
| 03 Jun 2004 | 90209598 | Punjab National Bank | ₹35 Lakh | Satisfied |
To see the full charge records of Acme Therapeutics (I) Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Acme Therapeutics (I) Private Limited has 14 court cases on record: 14 filed by Acme Therapeutics (I). 4 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 0 | 0 |
| District courts | 5 | 0 | 4 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against M/S Mohan Medical Hall and Another | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against Ms Ranvir Pharma and Another | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Disposed |
To see the full case history of Acme Therapeutics (I) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Acme Therapeutics (I) Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 155 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Akpash Pharmaceuticals Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Sellwell Pharmaceuticals Limited | |||
| Riemann Labs Private Limited |
To see the full MSME payment records of Acme Therapeutics (I) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Acme Therapeutics (I) has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCA3220A1ZY | Bihar | Active | 01 Jul 2017 |
| 23AADCA3220A1ZR | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Acme Therapeutics (I) Private Limited, buy the company report.
Recent activity
Acme Therapeutics (I) Private Limited has 7 board changes on record since 2001: 3 appointments and 4 cessations. The latest: Sanjay Kumar was appointed as Director on 21 Oct 2019.
7 earlier events are in the company report.
Frequently asked questions
Acme Therapeutics (I) is an active private limited company based in Panchkula, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 2001 (25+ years old) and is registered under CIN U24232HR2001PTC093261.
Acme Therapeutics (I) has 3 current directors:
- Banshidhar Kanhaiyalal - Director
- Gopal Krishna - Director
- Sanjay Kumar - Director
The latest financial statements of Acme Therapeutics (I) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Acme Therapeutics (I) is 10AADCA3220A1ZY, registered in Bihar. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 23AADCA3220A1ZR (Madhya Pradesh).
The CIN (Corporate Identification Number) of Acme Therapeutics (I) is U24232HR2001PTC093261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acme Therapeutics (I) has 14 court cases on record: 14 filed by the company. 4 are pending. Most are in the high courts.
Acme Therapeutics (I) was incorporated on 14 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Acme Therapeutics (I) by revenue are Intag Remedies Private Limited, Aashirwad Medicos Private Limited, Neoastra Drugs Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sanjay Kumar was appointed as Director on 21 Oct 2019. Binod Kumar Agarwal ceased to be Director on 19 Oct 2019. Rajesh Kumar Jain ceased to be Director on 23 Mar 2009. Acme Therapeutics (I) has 7 board changes on record in total.
Yes, Acme Therapeutics (I) is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0007205).
Acme Therapeutics (I) has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 155 overdue payments to 9 micro and small suppliers. The latest return was filed on 31 Oct 2019.
Acme Therapeutics (I) can be reached through the website atipl.in. Its registered office is in Panchkula, Haryana, India.

